Skip to main content
Premium Trial:

Request an Annual Quote

GIS, Sengenics Partner on Biomarkers for Early Detection of Cancer

NEW YORK (GenomeWeb News) – The Genome Institute of Singapore and Sengenics said today that they have formed a partnership to identify and validate auto-antibody signatures for the early detection of cancers.

The collaboration will use protein microarray technology from Senegenics' strategic partner, Oxford Gene Technology, and will focus initially on gastric and breast cancers.

As part of the partnership, Sengenics will establish its research biomarker discovery facility at GIS this year. The goal, noted GIS Executive Director Ng Huck Hui in a statement, is to combine the antibody biomarkers discovered via the collaboration with GIS's existing proprietary genomic data to "potentially develop a new range of powerful oncology prognostic tests specific to the Singaporean population."

According to Sengenics Commercial Director Johan Poole-Johnson, the partners anticipate completing the first phase of the project within 12 months.

Financial and other terms of the agreement were not disclosed.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.